Hospice Per Diem Payment Incentives: Why More Days Can Pay Better Than More Care

Hospice per diem payment incentives arise because Medicare pays for each day of routine home care, regardless of how many visits the hospice delivers. For healthcare staff scheduling visits, reviewing certifications or managing a hospice budget, that separates the day that earns revenue from the work that costs money. The pressure to keep patients enrolled and limit visits has survived changes to the rates. Understanding those changes helps explain the business decisions behind hospice fraud.

What Medicare Buys With a Hospice Day

Medicare’s daily hospice payment bundles care for the terminal illness and related conditions, including nursing, medical supplies, drugs and equipment. The hospice receives the payment and carries the cost of supplying that care. The payment covers more than the person who comes to the door. Geographic wage adjustments and quality-reporting requirements also affect what a provider receives.

There are four levels of care. Routine home care covers an ordinary enrolled day. Continuous home care supplies intensive care during a crisis at home, with payment based on hours. General inpatient care addresses pain or symptoms that cannot be managed in another setting. Inpatient respite gives the caregiver a break. These distinctions matter in hospice billing fraud, where the level claimed can differ from the care the patient needed or received.

Routine home care accounted for about 99% of Medicare hospice days in fiscal 2024, according to the Government Accountability Office’s payment review. The daily routine rate is the business model for almost the entire benefit.

Why Medicare Chose Daily Payment in 1983

Medicare chose the per diem partly because paying for every visit could encourage more services and require a more complicated payment system. The Government Accountability Office traces the original design to cost information from a study of cancer patients at 26 hospices. A daily payment let providers organize care within a fixed amount.

The competing concern was already on the table. In the 1983 implementation rule, commenters favoring payment by visit argued that daily payment was more vulnerable to fraud and abuse and less closely tied to patient needs. The agency chose daily payment and said it would monitor service frequency for patients receiving too little care.

The tradeoff was present at the beginning. Paying for visits rewards additional work. Paying for days allows the hospice to keep more of the payment when it does less work. The government chose the daily rate with an explicit promise to watch the care delivered under it.

The Lifetime Limit Disappeared in 1990

Congress removed the 210-day lifetime limit on Medicare hospice coverage, effective for services from January 1, 1990. That changed who paid when a patient lived longer than expected.

Before the lifetime limit disappeared, hospices had to supply uncompensated care to patients who outlived the limit and still needed hospice. In its 1997 review of hospice patients in nursing homes, the Inspector General described the repeal as a transfer of that financial risk from the hospice to Medicare.

Continued care now brought continued payment. The business could earn revenue from care it once supplied without payment.

What Happens If a Hospice Patient Lives Longer Than 6 Months?

A patient can continue receiving Medicare hospice care when the required recertifications support a prognosis of six months or less if the illness runs its normal course. The benefit provides two 90-day periods followed by unlimited 60-day periods.

The Balanced Budget Act of 1997 established that later sequence, replacing an unlimited fourth period with repeated eligibility reviews. It preserved continued coverage while requiring the hospice to revisit the clinical basis for it. Admission and recertification are where the patient’s condition, the physician’s judgment and the provider’s interest in continued payment meet.

The Cost Curve Runs in Both Directions

Hospice costs tend to rise at admission and near death, with less intensive care between them. A flat daily payment fits that U-shaped cost curve poorly. The length of the middle changes the economics of the whole stay.

The early concern ran in the opposite direction from today’s long-stay concern. In its 2000 report on shorter hospice stays, the Government Accountability Office explained that providers traditionally used lower-cost middle days to offset the more expensive beginning and end. Shorter stays left fewer days over which to spread those costs.

Longer stays make that same middle more valuable. The Medicare Payment Advisory Commission’s March 2026 report explains that providers furnish fewer services in the middle of a hospice episode, making long stays more profitable than short ones. Admissions, staffing and retention decisions all sit against that payment shape.

By October 2004, the Government Accountability Office’s report on hospice payment had identified a measurement problem as well. Its analysis of freestanding hospice cost reports found daily payments above estimated average daily costs. But Medicare’s own claims and cost reports lacked daily patient-level visit information, so the agency used proprietary data from a large hospice for that part of the work.

The agency paying for the day lacked the information needed to see what happened during it. It recommended collecting patient-specific visit and cost data and using them to reconsider the payment method.

Hospice Two Tier Payment and the Low Visit Incentive

The hospice two tier payment system reduced the reward for later days while leaving a low visit incentive within the routine daily rate. Effective January 1, 2016, the Centers for Medicare & Medicaid Services introduced a higher routine rate for the first 60 days and a lower rate from day 61 onward in its 2016 payment rule. The higher opening rate helped reflect the greater work at admission.

The agency also introduced the service intensity add-on for direct care by registered nurses and social workers during the last seven days of life, on days billed as routine home care. The add-on pays for qualifying care up to four hours a day, on top of the routine payment. The final rule included patients in nursing facilities, dropping a proposed exclusion.

The add-on made actual skilled care near death matter to payment. It left the middle of the stay paid by the day.

Under the fiscal 2027 payment rule, the routine base rates are about $236 for the opening tier and $186 for later days, for hospices meeting quality-reporting requirements, before local wage adjustments. The cost of an additional visit still comes out of that payment.

The 2020 Reform Moved Money Toward Intensive Care

For fiscal 2020, the Centers for Medicare & Medicaid Services raised the base rates for continuous home care, inpatient respite and general inpatient care, while reducing the routine home care base to fund the shift. Its cost analysis found the more intensive levels paid below costs and routine home care paid above costs.

The Government Accountability Office’s review puts the routine-base reduction at 2.7%, before the annual update.

The reform improved the payment balance between ordinary days and more expensive care. When management cuts needed visits, the patient loses health care while the daily payment keeps coming.

How Does the Medicare Hospice Cap Work?

The aggregate cap limits a hospice’s annual Medicare payments using an annual cap amount and its allocated beneficiary count. Payments above that ceiling must be returned. The cap applies across the provider’s patients. The fiscal 2027 cap amount is about $36,175 per beneficiary.

A new beneficiary can raise the ceiling, giving management another financial reason to push admissions. Near the cap, the incentive can turn toward discharging patients whose continued stays add to the repayment bill.

What Happens If a Hospice Exceeds Medicare’s 20% Inpatient Cap?

Medicare reduces payment for excess inpatient days to the routine home care rate and requires repayment of excess reimbursement. This separate cap limits inpatient days as a share of the hospice’s total Medicare care days.

Caps constrain the money retained at the provider level. They leave the basic relationship between enrolled days, visits and daily revenue in place. The Medicare Payment Advisory Commission has recommended tightening the aggregate cap.

What the Visit Data Show

Government studies have measured both long stays and low service intensity under daily payment. The Inspector General’s January 2015 assisted-living report examined beneficiaries receiving hospice care in 2012. For those receiving hospice care primarily in assisted living, the median total stay was 98 days, counting time in hospice back to 2007. Those receiving routine care in assisted living averaged 4.8 hours of visits a week.

The report also found that 25 hospices reported no visits to 210 assisted-living beneficiaries, for whom Medicare paid $2.3 million. Taxpayers paid for the enrolled days while the visit records stayed empty.

The Government Accountability Office returned to the payment question in June 2026. It examined selected beneficiaries discharged in 2024, using claims back to 2022.

The lowest-visit group averaged 2.5 visits per beneficiary per week, compared with 5.5 in the highest-visit group. The agency found that Medicare effectively paid the low-visit hospices twice as much per visit. It then estimated what comparable services would have cost using adjusted home health per-visit rates.

$7.6 billion

GAO’s estimated payment difference for comparable care in its selected beneficiary group.

$16.7 billion in hospice routine home care payments.

$9.1 billion estimated under adjusted home health per-visit rates.

Government Accountability Office, Medicare Hospice: Action Needed to Pay More Efficiently for Routine Home Care, June 2026

The Government Accountability Office asked Congress to consider directing a revision of routine home care payment. The Centers for Medicare & Medicaid Services said the law requires payment by day and limits its authority to restructure the system.

Paying for Care Without Paying for Invented Visits

A hybrid of daily and visit-based payment could change the incentives, but the design has to account for how providers respond. Quality, Reputation, and Reimbursement Design in the Hospice Industry, a 2026 Kansas State University working paper, used a model of California hospices to examine that tradeoff.

The model found that a hybrid could lower Medicare spending while maintaining its measure of quality, based on visits per patient-day. Simply lowering reimbursement worsened modeled quality. The paper also names a familiar problem:

That returns to the question Medicare faced at the start. A payment design has to support needed care while accounting for the incentive to bill for work that adds little or never happened.

Other alternatives have been tested. The Medicare Advantage hospice demonstration ran from 2021 through 2024 and ended on December 31, 2024. It tested a different arrangement for financing hospice inside participating plans.

Oversight has also expanded around the daily rate. The Centers for Medicare & Medicaid Services implemented the HOPE patient assessment tool in October 2025. Its fiscal 2027 final rule, effective October 1, 2026, made the election statement addendum mandatory and described the Service and Spending Variation Index. That index uses patterns in visits, stays, discharges and outside spending to identify providers for closer attention.

When the Census Drives the Decision

An insider can connect payment incentives to the instruction that changed a patient’s care or kept an unsupported claim going. Visit records, certification reviews, billing data and management messages show different parts of that decision.

Whistleblowers brought the case against Evercare Hospice, and the government joined it. In its complaint, the government alleged that management blocked a patient’s request to leave hospice because its census was too low:

The allegation puts the business pressure inside a patient decision. A census report shows how many people remain enrolled. The instruction explains why management wanted this patient kept there. That is the connection hospice fraud whistleblowers can bring from inside the business.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When the Budget Overrides the Care

If you know who cut the visits, overrode a discharge or demanded a certification the chart could not support, talk with our whistleblower experts about the decisions behind those paid days. We work beside you to connect the clinical record to the money and build your hospice whistleblower case. We bring in hospice fraud whistleblower lawyers who understand payment and eligibility disputes, and stay with you through the case.